Diabetes, a global pandemic.
Diabetes mellitus, commonly referred to as diabetes, is a chronic disease that is characterized by the pancreas not producing enough insulin or the cells of the body not responding properly to the insulin that is produced. As a result of the lack of pancreatic function or rejection of insulin by a person’s cells, a person with diabetes will experience high blood sugar levels over a prolonged period of time without treatment. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many short and long-term complications including ketoacidosis, hypoglycemia, cardiovascular disease, stroke, kidney failure, foot ulcers and damage to the eyes.
According to the World Health Organization, over 9% of the world’s population over the age of 18 has diabetes. In the United States alone, the American Diabetes Association estimates there are over 29 million people with diabetes.
Type 1, type 2 and gestational diabetes.
Type 1 diabetes results from the pancreas’ failure to produce enough insulin.A C-peptide test is often used to determine if the pancreas is producing insulin. Since C-peptide and insulin are produced at the same rate, C-peptide is a useful marker of insulin production. Type 1 diabetes is managed with insulin. Patients now have the option of acquiring insulin through needle injections, an insulin pen or via an insulin pump. Often referred to as juvenile diabetes, the cause of type 1 diabetes is unknown.
Type 2 diabetes starts with insulin resistance, when cells fail to respond to insulin properly. As the body becomes resistant to the effects of insulin, it compensates by producing and releasing more insulin. As Type 2 diabetes progresses, a complete lack of insulin can develop. People with type 2 diabetes are usually treated with oral drugs to stimulate their body to make more insulin and/or to cause their cells to be more sensitive to the insulin that is already produced. Type 2 diabetes is sometimes referred to as adult-onset diabetes. Exactly why people get Type 2 diabetes is unknown, although genetics and environmental factors, such as excess weight and inactivity, seem to be contributing factors.
Gestational diabetes is hyperglycemia, blood glucose values above normal, which occurs during pregnancy. Researchers don’t know why some women develop gestational diabetes and others do not. Women with gestational diabetes are at an increased risk of complications during pregnancy and delivery. They also have an increased risk of type 2 diabetes in the future. Gestational diabetes is diagnosed through prenatal screening, rather than reported symptoms.
Where Glooko fits in to the diabetes puzzle.
Understanding, tracking and managing patient diabetes data can be effective in improving patient outcomes and reducing ER visits, hospital stays and readmissions. Having a platform to do that easily, centrally and in a consistent manner makes healthcare providers more efficient and effective in their service of patients with diabetes.
Glooko allows people with diabetes and their care team to sync, review and analyze their glucose levels in context with their medication, fitness, biometric and carb intake data. Both patients and their healthcare provider have access to Glooko via a mobile app and a cloud-based web app. Both apps can be accessed anywhere and at anytime. Reminders, alerts, reports and analytics make it easier for users to review the who, what, where, when and why of when a patient experiences issues with their blood glucose levels. Graphs by time of day, day of week, and date, as well as statistics, put diabetes insights at the fingertips of the user – helping them to have the data and support they need to take control of their diabetes.